Irish-listed orphan drug develpment company Amryt Pharma is looking to expand its portfolio of treatments for rare diseases.

Positive contributions from acquisitions helped Dublin-listed orphan drug firm Amryt Pharma generate revenues of just over €1.35m in 2016, its first year as a commercial entity.